Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 114.76 Million CNY | -1.07% |
| 2022 | 116 Million CNY | 2.88% |
| 2021 | 112.75 Million CNY | -0.96% |
| 2020 | 113.84 Million CNY | 28.7% |
| 2019 | 88.46 Million CNY | -19.14% |
| 2018 | 109.4 Million CNY | -17.43% |
| 2017 | 132.5 Million CNY | 3.11% |
| 2016 | 128.5 Million CNY | 47.7% |
| 2015 | 87 Million CNY | -7.45% |
| 2014 | 94 Million CNY | -7.84% |
| 2013 | 102 Million CNY | -16.39% |
| 2012 | 121.99 Million CNY | 17.32% |
| 2011 | 103.98 Million CNY | 9.49% |
| 2010 | 94.97 Million CNY | 21.76% |
| 2009 | 78 Million CNY | 29.25% |
| 2008 | 60.35 Million CNY | 1.43% |
| 2007 | 59.5 Million CNY | -19.49% |
| 2006 | 73.9 Million CNY | -17.34% |
| 2005 | 89.4 Million CNY | 34.64% |
| 2004 | 66.4 Million CNY | 13.48% |
| 2003 | 58.51 Million CNY | -22.4% |
| 2002 | 75.4 Million CNY | -32.92% |
| 2001 | 112.4 Million CNY | -9.72% |
| 2000 | 124.5 Million CNY | 164.91% |
| 1999 | 47 Million CNY | 18.06% |
| 1998 | 39.81 Million CNY | 56.44% |
| 1997 | 25.44 Million CNY | -18.15% |
| 1996 | 31.09 Million CNY | 137.65% |
| 1995 | 13.08 Million CNY | 27.13% |
| 1994 | 10.29 Million CNY | -47.47% |
| 1993 | 19.59 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 106.69 Million CNY | 31.12% |
| 2024 Q2 | 82.95 Million CNY | 0.2% |
| 2024 Q1 | 82.79 Million CNY | -27.86% |
| 2023 Q4 | 114.76 Million CNY | 1.78% |
| 2023 Q1 | 115.69 Million CNY | -0.26% |
| 2023 Q2 | 114.82 Million CNY | -0.76% |
| 2023 FY | 114.76 Million CNY | -1.07% |
| 2023 Q3 | 112.75 Million CNY | -1.8% |
| 2022 Q4 | 116 Million CNY | 5.28% |
| 2022 FY | 116 Million CNY | 2.88% |
| 2022 Q1 | 111.81 Million CNY | -0.84% |
| 2022 Q2 | 110.52 Million CNY | -1.16% |
| 2022 Q3 | 110.18 Million CNY | -0.3% |
| 2021 Q4 | 112.75 Million CNY | 5.32% |
| 2021 Q1 | 113.24 Million CNY | -0.53% |
| 2021 FY | 112.75 Million CNY | -0.96% |
| 2021 Q2 | 102.54 Million CNY | -9.45% |
| 2021 Q3 | 107.06 Million CNY | 4.41% |
| 2020 FY | 113.84 Million CNY | 28.7% |
| 2020 Q1 | 98.46 Million CNY | 11.3% |
| 2020 Q2 | 105.26 Million CNY | 6.91% |
| 2020 Q3 | 114.24 Million CNY | 8.53% |
| 2020 Q4 | 113.84 Million CNY | -0.34% |
| 2019 Q1 | 84.7 Million CNY | -22.58% |
| 2019 Q4 | 88.46 Million CNY | 0.52% |
| 2019 FY | 88.46 Million CNY | -19.14% |
| 2019 Q3 | 88 Million CNY | -1.12% |
| 2019 Q2 | 89 Million CNY | 5.08% |
| 2018 Q2 | 123.3 Million CNY | 25.18% |
| 2018 Q1 | 98.5 Million CNY | -25.66% |
| 2018 Q4 | 109.4 Million CNY | -8.83% |
| 2018 FY | 109.4 Million CNY | -17.43% |
| 2018 Q3 | 120 Million CNY | -2.68% |
| 2017 Q2 | 139 Million CNY | 15.83% |
| 2017 Q4 | 132.5 Million CNY | 1.15% |
| 2017 FY | 132.5 Million CNY | 3.11% |
| 2017 Q1 | 120 Million CNY | -6.61% |
| 2017 Q3 | 131 Million CNY | -5.76% |
| 2016 Q1 | 109.5 Million CNY | 25.86% |
| 2016 Q2 | 116.5 Million CNY | 6.39% |
| 2016 Q4 | 128.5 Million CNY | 1.18% |
| 2016 Q3 | 127 Million CNY | 9.01% |
| 2016 FY | 128.5 Million CNY | 47.7% |
| 2015 FY | 87 Million CNY | -7.45% |
| 2015 Q2 | 89 Million CNY | -7.29% |
| 2015 Q3 | 89.5 Million CNY | 0.56% |
| 2015 Q4 | 87 Million CNY | -2.79% |
| 2015 Q1 | 96 Million CNY | 2.13% |
| 2014 Q1 | 101.5 Million CNY | -0.49% |
| 2014 Q2 | 89 Million CNY | -12.32% |
| 2014 Q3 | 92 Million CNY | 3.37% |
| 2014 FY | 94 Million CNY | -7.84% |
| 2014 Q4 | 94 Million CNY | 2.17% |
| 2013 Q3 | 108 Million CNY | -2.02% |
| 2013 Q4 | 102 Million CNY | -5.56% |
| 2013 FY | 102 Million CNY | -16.39% |
| 2013 Q1 | 121.95 Million CNY | -0.04% |
| 2013 Q2 | 110.23 Million CNY | -9.61% |
| 2012 FY | 121.99 Million CNY | 17.32% |
| 2012 Q1 | 99.54 Million CNY | -4.27% |
| 2012 Q4 | 121.99 Million CNY | 7.93% |
| 2012 Q2 | 95.98 Million CNY | -3.57% |
| 2012 Q3 | 113.03 Million CNY | 17.76% |
| 2011 FY | 103.98 Million CNY | 9.49% |
| 2011 Q3 | 100.98 Million CNY | -0.01% |
| 2011 Q2 | 100.99 Million CNY | 0.02% |
| 2011 Q4 | 103.98 Million CNY | 2.97% |
| 2011 Q1 | 100.97 Million CNY | 6.32% |
| 2010 FY | 94.97 Million CNY | 21.76% |
| 2010 Q2 | 79.5 Million CNY | 7.43% |
| 2010 Q3 | 89.99 Million CNY | 13.21% |
| 2010 Q4 | 94.97 Million CNY | 5.53% |
| 2010 Q1 | 74 Million CNY | -5.13% |
| 2009 Q2 | 68 Million CNY | 4.53% |
| 2009 Q3 | 60 Million CNY | -11.76% |
| 2009 Q4 | 78 Million CNY | 30.0% |
| 2009 FY | 78 Million CNY | 29.25% |
| 2009 Q1 | 65.05 Million CNY | 7.79% |
| 2008 Q3 | 58.4 Million CNY | 21.67% |
| 2008 Q1 | 54.35 Million CNY | -8.66% |
| 2008 Q4 | 60.35 Million CNY | 3.34% |
| 2008 FY | 60.35 Million CNY | 1.43% |
| 2008 Q2 | 48 Million CNY | -11.68% |
| 2007 Q4 | 59.5 Million CNY | -1.57% |
| 2007 Q3 | 60.45 Million CNY | 3.33% |
| 2007 FY | 59.5 Million CNY | -19.49% |
| 2007 Q2 | 58.5 Million CNY | -18.86% |
| 2007 Q1 | 72.1 Million CNY | -2.44% |
| 2006 Q3 | 83.4 Million CNY | 1.21% |
| 2006 Q1 | 80.4 Million CNY | -10.07% |
| 2006 Q4 | 73.9 Million CNY | -11.39% |
| 2006 FY | 73.9 Million CNY | -17.34% |
| 2006 Q2 | 82.4 Million CNY | 2.49% |
| 2005 Q4 | 89.4 Million CNY | 28.82% |
| 2005 FY | 89.4 Million CNY | 34.64% |
| 2005 Q3 | 69.4 Million CNY | 2.97% |
| 2005 Q2 | 67.4 Million CNY | -6.91% |
| 2005 Q1 | 72.4 Million CNY | 9.04% |
| 2004 Q1 | 73 Million CNY | 24.76% |
| 2004 Q2 | 69.1 Million CNY | -5.34% |
| 2004 Q3 | 58.4 Million CNY | -15.48% |
| 2004 FY | 66.4 Million CNY | 13.48% |
| 2004 Q4 | 66.4 Million CNY | 13.7% |
| 2003 Q4 | 58.51 Million CNY | -3.31% |
| 2003 Q1 | 88.9 Million CNY | 17.9% |
| 2003 Q3 | 60.51 Million CNY | -21.83% |
| 2003 Q2 | 77.41 Million CNY | -12.92% |
| 2003 FY | 58.51 Million CNY | -22.4% |
| 2002 FY | 75.4 Million CNY | -32.92% |
| 2002 Q3 | 74.4 Million CNY | -40.67% |
| 2002 Q2 | 125.4 Million CNY | 15.68% |
| 2002 Q1 | 108.4 Million CNY | -3.56% |
| 2002 Q4 | 75.4 Million CNY | 1.34% |
| 2001 Q4 | 112.4 Million CNY | 0.0% |
| 2001 Q2 | 85.5 Million CNY | 0.0% |
| 2001 FY | 112.4 Million CNY | -9.72% |
| 2000 Q4 | 124.5 Million CNY | 0.0% |
| 2000 FY | 124.5 Million CNY | 164.91% |
| 2000 Q2 | 133 Million CNY | 0.0% |
| 1999 FY | 47 Million CNY | 18.06% |
| 1999 Q2 | 56.5 Million CNY | 0.0% |
| 1999 Q4 | 47 Million CNY | 0.0% |
| 1998 FY | 39.81 Million CNY | 56.44% |
| 1998 Q4 | 39.81 Million CNY | 0.0% |
| 1998 Q2 | 45.56 Million CNY | 0.0% |
| 1997 Q4 | 25.44 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1997 FY | 25.44 Million CNY | -18.15% |
| 1996 FY | 31.09 Million CNY | 137.65% |
| 1996 Q4 | 31.09 Million CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1995 FY | 13.08 Million CNY | 27.13% |
| 1995 Q4 | 13.08 Million CNY | 0.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | 10.29 Million CNY | -47.47% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 Q4 | 10.29 Million CNY | 0.0% |
| 1993 FY | 19.59 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | -52.663% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.33 Billion CNY | 91.389% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | 88.923% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 405.85 Million CNY | 71.722% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -284.232% |
| NanJing Pharmaceutical Company Limited | 11.61 Billion CNY | 99.012% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 291.35 Million CNY | 60.61% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 150 Million CNY | 23.489% |